TGFB1 and cancer: TGFβ1 signaling pathway has been shown to impede the hTERT gene expression and telomerase activity thorough its downstream factors in a diversity of cancers, such as kidney cancer, breast cancer, colorectal cancer, and lung cancer[8-10].